The growth and maturation of the Winship Cancer Institute (Winship) as a new CCSG-supported cancer center requires the development of a strong and highly effective administration. The past two years have witnessed a full administrative reorganization and new personnel recruitment to Winship's administrative team. These transitions were accomplished as a process fully integrated with the development of the Winship Strategic Plan 2010-2015. The current capabilities and responsibilities of the Winship administrative team include the following roles: * Planning and evaluation activities to promote interdisciplinary and translational research * Financial management of all Winship funds and accounts * Shared resource management including budgetary oversight, rate structuring, and reporting * Management of Winship's facilities, space, and equipment * Support and coordination of membership applications and review processes * Coordination of information technology and informatics needs * Communications, development, public affairs, and education programs * Personnel management and human resource services * Management and coordination of Winship pilot grant program * Executive support to all Winship committees within the cancer center's enhanced organizational structure To fulfill its vision, Winship must expand its research enterprise, and highly effective administrative support will be critical in achieving this. Winship has the appropriate administrative processes to manage the cancer center's growth and a highly skilled administrative team to implement its strategic plan.
Winship administration provides direct grant, research, space, and other administrative services to 146 cancer center members and five shared resource facilities. The administrative team will optimize CCSG funds to continue to facilitate cancer research and manage Winship's essential operations.
|Patel, Kirtesh R; Chowdhary, Mudit; Switchenko, Jeffrey M et al. (2016) BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis. Melanoma Res 26:387-94|
|Berg, Carla J; Stratton, Erin; Esiashvili, Natia et al. (2016) Young Adult Cancer Survivors' Experience with Cancer Treatment and Follow-Up Care and Perceptions of Barriers to Engaging in Recommended Care. J Cancer Educ 31:430-42|
|Yoshida, Michihiro; He, Peijian; Yun, C Chris (2016) Transgenic Expression of Human Lysophosphatidic Acid Receptor LPA2 in Mouse Intestinal Epithelial Cells Induces Intestinal Dysplasia. PLoS One 11:e0154527|
|Horton, John R; Liu, Xu; Gale, Molly et al. (2016) Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds. Cell Chem Biol 23:769-81|
|Bonner, Michael Y; Karlsson, Isabella; Rodolfo, Monica et al. (2016) Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo. Oncotarget 7:12857-68|
|Bajpai, R; Matulis, S M; Wei, C et al. (2016) Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax. Oncogene 35:3955-64|
|Xiao, Canhua; Miller, Andrew H; Felger, Jennifer et al. (2016) A prospective study of quality of life in breast cancer patients undergoing radiation therapy. Adv Radiat Oncol 1:10-16|
|Owonikoko, Taofeek K; Zhang, Guojing; Kim, Hyun S et al. (2016) Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer. J Transl Med 14:111|
|Oliver, Daniel E; Patel, Kirtesh R; Switchenko, Jeffrey et al. (2016) Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma. Melanoma Res 26:35-41|
|Liu, Min; Wang, Hongyan; Lee, Solah et al. (2016) DNA repair pathway choice at various conditions immediately post irradiation. Int J Radiat Biol 92:819-822|
Showing the most recent 10 out of 210 publications